J0190 HCPCS Level II code: Injection, biperiden lactate, per 5 mg
CMS terminated J0190: its last date of service was Dec 31, 2025. It stays here for looking up older claims; newer services need a current code.
Official description
J0190Injection, biperiden lactate, per 5 mg
Short description: Inj biperiden lactate/5 mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J0190 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 1982
- Terminated after
- Dec 31, 2025
Where J0190 sits
- 1J codesDrugs administered other than orally
- 2Terminated J0190Injection, biperiden lactate, per 5 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code J0190 still valid?
No. CMS terminated J0190; its last date of service was Dec 31, 2025. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover J0190?
CMS lists J0190’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J0190
All J codesJ0177Injection, aflibercept hd, 1 mgJ0178Injection, aflibercept, 1 mgJ0179Injection, brolucizumab-dbll, 1 mgJ0180Injection, agalsidase beta, 1 mgJ0184Injection, amisulpride, 1 mgJ0185Injection, aprepitant, 1 mgJ0200Injection, alatrofloxacin mesylate, 100 mgJ0202Injection, alemtuzumab, 1 mgJ0205Injection, alglucerase, per 10 unitsJ0206Injection, allopurinol sodium, 1 mgJ0207Injection, amifostine, 500 mgJ0208Injection, sodium thiosulfate (pedmark), 100 mg